Business Description
Mymetics Corp
NAICS : 325412
SIC : 2834
ISIN : US62856A1025
Description
Mymetics Corp is a vaccine company and is focused on the research and development of next-generation vaccines for infectious and life-disabling diseases. Its vaccine candidates in the pipeline include HIV-1/AIDS, malaria, and Covid-19, and intranasal influenza, RSV, Chikungunyaand HSV vaccine candidate programs.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -753.75 | |||||
Debt-to-Equity | -0.99 | |||||
Debt-to-EBITDA | -8.5 | |||||
Piotroski F-Score | 4/9 | |||||
Beneish M-Score | -184.43 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -70.9 | |||||
3-Year EBITDA Growth Rate | -8.9 | |||||
3-Year EPS without NRI Growth Rate | -24 | |||||
3-Year FCF Growth Rate | -16.9 | |||||
3-Year Book Growth Rate | -6.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 0.37 | |||||
14-Day RSI | 18 | |||||
6-1 Month Momentum % | -99.55 | |||||
12-1 Month Momentum % | -99.94 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Days Sales Outstanding | 3345.83 | |||||
Days Payable | 162.12 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -19600 | |||||
Operating Margin % | -43500 | |||||
Net Margin % | -207816.67 | |||||
FCF Margin % | -31066.67 | |||||
ROA % | -263.35 | |||||
ROIC % | -3.21 | |||||
ROC (Joel Greenblatt) % | -7019.32 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.03 | |||||
EV-to-EBIT | -8.59 | |||||
EV-to-EBITDA | -8.6 | |||||
EV-to-Revenue | 13522.67 | |||||
EV-to-FCF | -43.53 | |||||
Earnings Yield (Greenblatt) % | -11.64 | |||||
FCF Yield % | -89.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MYMX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mymetics Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.006 | ||
EPS (TTM) ($) | -96.954 | ||
Beta | 2.34 | ||
Volatility % | 356.35 | ||
14-Day RSI | 18 | ||
14-Day ATR ($) | 0.000405 | ||
20-Day SMA ($) | 0.00235 | ||
12-1 Month Momentum % | -99.94 | ||
52-Week Range ($) | 0.0009 - 56.6 | ||
Shares Outstanding (Mil) | 0.15 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Mymetics Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Mymetics Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Mymetics Corp Frequently Asked Questions
What is Mymetics Corp(MYMX)'s stock price today?
The current price of MYMX is $0.00. The 52 week high of MYMX is $56.60 and 52 week low is $0.00.
When is next earnings date of Mymetics Corp(MYMX)?
The next earnings date of Mymetics Corp(MYMX) is .
Does Mymetics Corp(MYMX) pay dividends? If so, how much?
Mymetics Corp(MYMX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |